C
NVCR icon

Covestor’s NovoCure NVCR Stock Holding History

Covestor’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7K Buy
493
+18
+4% +$272 ﹤0.01% 1793
2026
Q1 		$5K Buy
475
+73
+18% +$912 ﹤0.01% 1812
2025
Q4 		$5K Hold
402
– – ﹤0.01% 1848
2025
Q3 		$5K Sell
402
-1
-0.2% -$13 ﹤0.01% 1853
2025
Q2 		$7K Sell
403
-1
-0.2% -$17 ﹤0.01% 1714
2025
Q1 		$7K Sell
404
-222
-35% -$5.04K ﹤0.01% 1672
2024
Q4 		$19K Buy
626
+1
+0.2% +$21 0.01% 1222
2024
Q3 		$10K Hold
625
– – 0.01% 1568
2024
Q2 		$11K Buy
625
+2
+0.3% +$35 0.01% 1477
2024
Q1 		$10K Sell
623
-1
-0.2% -$15 0.01% 1599
2023
Q4 		$9K Buy
624
+387
+163% +$5.18K 0.01% 1648
2023
Q3 		$4K Buy
237
+131
+124% +$3.78K ﹤0.01% 1746
2023
Q2 		$4K Sell
106
-1
-0.9% -$62 ﹤0.01% 1729
2023
Q1 		$6K Buy
107
+2
+2% +$160 0.01% 1526
2022
Q4 		$8K Hold
105
– – 0.01% 1428
2022
Q3 		$8K Buy
105
+103
+5,150% +$8.03K 0.01% 1352
2022
Q2 		$0 Sell
2
-2
-50% -$151 ﹤0.01% 2210
2022
Q1 		$0 Hold
4
– – ﹤0.01% 2324
2021
Q4 		$0 Buy
+4
New +$402 ﹤0.01% 2233

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Covestor's NVCR Position: Q2 2026 in Review

Covestor increased its NovoCure (NVCR) stake by 3.8% in Q2 2026, buying an estimated $272 and bringing the position to 493 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1793.

Covestor first reported a position in NVCR in Q4 2021 and has held it in 19 quarters since. The position peaked at $19K in Q4 2024. 217 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Covestor held 493 shares of NovoCure worth $7K as of Q2 2026.
  • Covestor bought 18 NovoCure shares in Q2 2026, an estimated $272.
  • NovoCure made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #1793 holding.
  • Covestor first reported a position in NovoCure in Q4 2021 and has held it in 19 quarters since.
  • Covestor's NovoCure position peaked at $19K in Q4 2024.
  • 217 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.